Find any stock by ticker or company name
ASE – Real vaqt narxi. Valyuta: USD
2.80
+0.02 (0.72%)
Bozor ochiq: Aug 12, 2026, 1:05 PM EDT
2.81
+0.03 (1.07%)
Oldingi bozordan keyin: Aug 11, 2026, 7:59 PM EDT
Serina Therapeutics, Inc., bir biotexnologiya kompaniyasi, nevrologik kasalliklar va og'riqlarni davolash uchun dori vositalarini ishlab chiqadi. Uning asosiy mahsulot nomzodi SER 252 (POZ-apomorfin) bo'lib, bu ilg'or Parkinson kasalligini davolash uchun POZ konjugati bo'lib, 1-faza klinik sinovlarida; va POZ-lipidlar, lipid nanozarralaridagi PEG-lipidlar uchun immunogen bo'lmagan muqobil hisoblanadi. Kompaniya, shuningdek, 1a-faza klinik sinovlarini yakunlagan, erta Parkinson kasalligi va Restsiz oyoq sindromini davolash uchun rotigotinning POZ konjugati bo'lgan SER 214ni ishlab chiqmoqda. Bundan tashqari, u yuqumli kasalliklar uchun lipid nanozarralari orqali etkazib beriladigan RNK vaktsinalarida POZ texnologiyasini ishlab chiqmoqda. SER-252ni ishlab chiqish faoliyatini qo'llab-quvvatlash uchun Gannet BioChem bilan hamkorlik shartnomasiga ega. Serina Therapeutics, Inc. 2006-yilda tashkil etilgan va Xantsvill, Alabama shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Balkrishan Gill Ph.D. | Executive Co-Chairman of the Board |
| Dr. J. Milton Harris Ph.D. | Co-Founder, Director Emeritus & Chair of Scientific Advisory Board |
| Dr. Joshua Thomas Ph.D. | Head of Chemistry |
| Dr. Randall W. Moreadith M.D., Ph.D. | Chief Development Officer |
| Dr. Srini Tenjarla Ph.D. | Chief Technical Operations Officer |
| Mr. Gregory S. Curhan | Chief Financial Officer |
| Mr. Steven A. Ledger | CEO & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-07-23 | 8-K | ser-20260719.htm |
| 2026-07-22 | 8-K | ser-20260723xappointmentof.htm |
| 2026-06-24 | 8-K | ser-20260617.htm |
| 2026-05-22 | S-3 | forms-3.htm |
| 2026-05-14 | 8-K | ser-20260514.htm |
| 2026-05-14 | 10-Q | ser-20260331.htm |
| 2026-04-28 | DEFA14A | a2026proxydefa14a.htm |
| 2026-04-27 | DEF 14A | ser-20260427.htm |
| 2026-04-21 | 8-K | ser-20260415.htm |
| 2026-04-17 | PRE 14A | ser-20260417.htm |